[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Rofecoxib Market Status, Trends and COVID-19 Impact Report 2021

February 2022 | 121 pages | ID: G0FD10FF7E41EN
BisReport Information Consulting CO., Ltd

US$ 2,350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In the past few years, the Rofecoxib market experienced a huge change under the influence
of COVID-19, the global market size of Rofecoxib reached (2021 Market size XXXX) million $
in 2021 from (2016 Market size XXXX) in 2016 with a CAGR of xxx from 2016-2021 is. As of
now, the global COVID-19 Coronavirus Cases have exceeded 200 million, and the global
epidemic has been basically under control, therefore, the World Bank has estimated the
global economic growth in 2021 and 2022. The World Bank predicts that the global
economic output is expected to expand 4 percent in 2021 while 3.8 percent in 2022.
According to our research on Rofecoxib market and global economic environment, we
forecast that the global market size of Rofecoxib will reach (2026 Market size XXXX) million
$ in 2026 with a CAGR of % from 2021-2026.

Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.

The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Rofecoxib Market Status, Trends and COVID-19
Impact Report 2021, which provides a comprehensive analysis of the global Rofecoxib
market , This Report covers the manufacturer data, including: sales volume, price, revenue,
gross margin, business distribution etc., these data help the consumer know about the
competitors better. This report also covers all the regions and countries of the world, which
shows the regional development status, including market size, volume and value, as well as
price data. Besides, the report also covers segment data, including: type wise, industry wise,
channel wise etc. all the data period is from 2015-2021E, this report also provide forecast
data from 2021-2026.

Section 1: 100 USD——Market Overview

Section (2 3): 1200 USD——Manufacturer Detail
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau

Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)

Section (5 6 7): 700 USD——
Product Type Segmentation
Oral Suspension.
Tablet-Form

Application Segmentation
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine/Dysmenorrhea

Channel (Direct Sales, Distribution Channel) Segmentation

Section 8: 500 USD——Market Forecast (2021-2026)

Section 9: 600 USD——Downstream Customers

Section 10: 200 USD——Raw Material and Manufacturing Cost

Section 11: 500 USD——Conclusion

Section 12: Research Method and Data Source

SECTION 1 ROFECOXIB MARKET OVERVIEW

1.1 Rofecoxib Market Scope
1.2 COVID-19 Impact on Rofecoxib Market
1.3 Global Rofecoxib Market Status and Forecast Overview
  1.3.1 Global Rofecoxib Market Status 2016-2021
  1.3.2 Global Rofecoxib Market Forecast 2021-2026

SECTION 2 GLOBAL ROFECOXIB MARKET MANUFACTURER SHARE

2.1 Global Manufacturer Rofecoxib Sales Volume
2.2 Global Manufacturer Rofecoxib Business Revenue

SECTION 3 MANUFACTURER ROFECOXIB BUSINESS INTRODUCTION

3.1 Merck Rofecoxib Business Introduction
  3.1.1 Merck Rofecoxib Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.1.2 Merck Rofecoxib Business Distribution by Region
  3.1.3 Merck Interview Record
  3.1.4 Merck Rofecoxib Business Profile
  3.1.5 Merck Rofecoxib Product Specification
3.2 Chengdu Meinkai Chemical Co. LTD Rofecoxib Business Introduction
  3.2.1 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales Volume, Price, Revenue and Gross
margin 2016-2021
  3.2.2 Chengdu Meinkai Chemical Co. LTD Rofecoxib Business Distribution by Region
  3.2.3 Interview Record
  3.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Business Overview
  3.2.5 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Specification
3.3 Manufacturer three Rofecoxib Business Introduction
  3.3.1 Manufacturer three Rofecoxib Sales Volume, Price, Revenue and Gross margin 2016-
2021
  3.3.2 Manufacturer three Rofecoxib Business Distribution by Region
  3.3.3 Interview Record
  3.3.4 Manufacturer three Rofecoxib Business Overview
  3.3.5 Manufacturer three Rofecoxib Product Specification

SECTION 4 GLOBAL ROFECOXIB MARKET SEGMENTATION (BY REGION)

4.1 North America Country
  4.1.1 United States Rofecoxib Market Size and Price Analysis 2016-2021
  4.1.2 Canada Rofecoxib Market Size and Price Analysis 2016-2021
  4.1.3 Mexico Rofecoxib Market Size and Price Analysis 2016-2021
4.2 South America Country
  4.2.1 Brazil Rofecoxib Market Size and Price Analysis 2016-2021
  4.2.2 Argentina Rofecoxib Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
  4.3.1 China Rofecoxib Market Size and Price Analysis 2016-2021
  4.3.2 Japan Rofecoxib Market Size and Price Analysis 2016-2021
  4.3.3 India Rofecoxib Market Size and Price Analysis 2016-2021
  4.3.4 Korea Rofecoxib Market Size and Price Analysis 2016-2021
  4.3.5 Southeast Asia Rofecoxib Market Size and Price Analysis 2016-2021
4.4 Europe Country
  4.4.1 Germany Rofecoxib Market Size and Price Analysis 2016-2021
  4.4.2 UK Rofecoxib Market Size and Price Analysis 2016-2021
  4.4.3 France Rofecoxib Market Size and Price Analysis 2016-2021
  4.4.4 Spain Rofecoxib Market Size and Price Analysis 2016-2021
  4.4.5 Italy Rofecoxib Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
  4.5.1 Africa Rofecoxib Market Size and Price Analysis 2016-2021
  4.5.2 Middle East Rofecoxib Market Size and Price Analysis 2016-2021
4.6 Global Rofecoxib Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Rofecoxib Market Segmentation (By Region) Analysis

SECTION 5 GLOBAL ROFECOXIB MARKET SEGMENTATION (BY PRODUCT TYPE)

5.1 Product Introduction by Type
  5.1.1 Oral Suspension. Product Introduction
  5.1.2 Tablet-Form Product Introduction
5.2 Global Rofecoxib Sales Volume by Tablet-Form016-2021
5.3 Global Rofecoxib Market Size by Tablet-Form016-2021
5.4 Different Rofecoxib Product Type Price 2016-2021
5.5 Global Rofecoxib Market Segmentation (By Type) Analysis

SECTION 6 GLOBAL ROFECOXIB MARKET SEGMENTATION (BY APPLICATION)

6.1 Global Rofecoxib Sales Volume by Application 2016-2021
6.2 Global Rofecoxib Market Size by Application 2016-2021
6.2 Rofecoxib Price in Different Application Field 2016-2021
6.3 Global Rofecoxib Market Segmentation (By Application) Analysis

SECTION 7 GLOBAL ROFECOXIB MARKET SEGMENTATION (BY CHANNEL)

7.1 Global Rofecoxib Market Segmentation (By Channel) Sales Volume and Share 2016-2021
7.2 Global Rofecoxib Market Segmentation (By Channel) Analysis

SECTION 8 ROFECOXIB MARKET FORECAST 2021-2026

8.1 Rofecoxib Segmentation Market Forecast 2021-2026 (By Region)
8.2 Rofecoxib Segmentation Market Forecast 2021-2026 (By Type)
8.3 Rofecoxib Segmentation Market Forecast 2021-2026 (By Application)
8.4 Rofecoxib Segmentation Market Forecast 2021-2026 (By Channel)
8.5 Global Rofecoxib Price Forecast

SECTION 9 ROFECOXIB APPLICATION AND CLIENT ANALYSIS

9.1 Osteoarthritis Customers
9.2 Rheumatoid Arthritis Customers
9.3 Juvenile Rheumatoid Arthritis Customers
9.4 Acute Pain Conditions Customers
9.5 Migraine/Dysmenorrhea Customers

SECTION 10 ROFECOXIB MANUFACTURING COST OF ANALYSIS

11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview

SECTION 11 CONCLUSION

SECTION 12 METHODOLOGY AND DATA SOURCE

CHART AND FIGURE

Figure Rofecoxib Product Picture
Chart Global Rofecoxib Market Size (with or without the impact of COVID-19)
Chart Global Rofecoxib Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Rofecoxib Market Size (Million $) and Growth Rate 2016-2021
Chart Global Rofecoxib Sales Volume (Units) and Growth Rate 2021-2026
Chart Global Rofecoxib Market Size (Million $) and Growth Rate 2021-2026
Chart 2016-2021 Global Manufacturer Rofecoxib Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Rofecoxib Sales Volume Share
Chart 2016-2021 Global Manufacturer Rofecoxib Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Rofecoxib Business Revenue Share
Chart Merck Rofecoxib Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Merck Rofecoxib Business Distribution
Chart Merck Interview Record (Partly)
Chart Merck Rofecoxib Business Profile
Table Merck Rofecoxib Product Specification
Chart Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales Volume, Price, Revenue and Gross
margin 2016-2021
Chart Chengdu Meinkai Chemical Co. LTD Rofecoxib Business Distribution
Chart Chengdu Meinkai Chemical Co. LTD Interview Record (Partly)
Chart Chengdu Meinkai Chemical Co. LTD Rofecoxib Business Overview
Table Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Specification


More Publications